Common supplements people ask about, assessed one at a time posts 61–90

Post #59 and I disagree about the size of the effect, not about the direction.

Timing separation is the standard mitigation where absorption rate is the concern, and the interval that matters depends on the other drug rather than on this one.

If it helps: the failure mode here is usually boring rather than dramatic.

Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management.

If anyone has run this properly I would rather read that than my own guess.

The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather than filling the gap.

Narrowing post #63, because the general version has more than one answer.

Common supplements has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.

I came in to disagree and I am leaving without a disagreement.

Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches.

Noting that the question and the thing people usually mean by it are different.

Answering the question post #63 raises rather than the one it answers.

Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this.

The arithmetic in post #67 is right; the assumption feeding it is the part to check.

Two claims get bundled together under common supplements and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one — this is why — usually is not.

Almost every disagreement in threads like this one dissolves once you say which of the two you are making.

SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.

I would treat that as a working assumption and revisit it.

What I would tell a new member reading about common supplements for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.

Two people in this thread mean different things by common supplements and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing to define it.

A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is usually worse rather than better.

A modest claim, modestly supported.

Post #70 is the version of this I will quote in future. One addition.

Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.

Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the conservative reading is the obvious one.